Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual im...

por Flavell, D J, Boehm, D A, Noss, A, Warnes, S L, Flavell, S U
Publicado 2001

Dacarbazine and interferon α with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)

por Hauschild, A, Garbe, C, Stolz, W, Ellwanger, U, Seiter, S, Dummer, R, Ugurel, S, Sebastian, G, Nashan, D, Linse, R, Achtelik, W, Mohr, P, Kaufmann, R, Fey, M, Ulrich, J, Tilgen, W
Publicado 2001

Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

por Kamai, T, Takagi, K, Asami, H, Ito, Y, Oshima, H, Yoshida, K-I
Publicado 2001

Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data

por Choma, D, Daurès, J-P, Quantin, X, Pujol, J L
Publicado 2001

Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy

por Huisman, C, Biesma, B, Postmus, P E, Giaccone, G, Schramel, F M N H, Smit, E F
Publicado 2001

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma

por Stokke, T, DeAngelis, P, Smedshammer, L, Galteland, E, Steen, H B, Smeland, E B, Delabie, J, Holte, H
Publicado 2001

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours

por Francis, R J, Sharma, S K, Springer, C, Green, A J, Hope-Stone, L D, Sena, L, Martin, J, Adamson, K L, Robbins, A, Gumbrell, L, O'Malley, D, Tsiompanou, E, Shahbakhti, H, Webley, S, Hochhauser, D, Hilson, A J, Blakey, D, Begent, R H J
Publicado 2002

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

por Kollmannsberger, C, Rick, O, Klaproth, H, Kubin, T, Sayer, H G, Hentrich, M, Welslau, M, Mayer, F, Kuczyk, M, Spott, C, Kanz, L, Bokemeyer, C
Publicado 2002

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes

por Tsavaris, N, Kosmas, C, Vadiaka, M, Kanelopoulos, P, Boulamatsis, D
Publicado 2002

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice

por Weimar, I S, Weijer, K, Berk, P C M van den, Muller, E J, Miranda, N, Bakker, A Q, Heemskerk, M H M, Hekman, A, Gast, G C de, Gerritsen, W R
Publicado 1999

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

por Herpen, C M L van, Jansen, R L H, Kruit, W H J, Hoekman, K, Groenewegen, G, Osanto, S, Mulder, P H M De
Publicado 2000

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkyl...

por Pujol, J-L, Carestia, Daurès, J-P
Publicado 2000

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

por Kollmannsberger, C, Quietzsch, D, Haag, C, Lingenfelser, T, Schroeder, M, Hartmann, J T, Baronius, W, Hempel, V, Clemens, M, Kanz, L, Bokemeyer, C
Publicado 2000

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

por Giatromanolaki, A, Koukourakis, M I, Sivridis, E, Turley, H, Talks, K, Pezzella, F, Gatter, K C, Harris, A L
Publicado 2001

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer

por Kawahara, M, Furuse, K, Segawa, Y, Yoshimori, K, Matsui, K, Kudoh, S, Hasegawa, K, Niitani, H
Publicado 2001

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer

por Chang, A, Yousef, G M, Scorilas, A, Grass, L, Sismondi, P, Ponzone, R, Diamandis, E P
Publicado 2002

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane

por Anderson, H, Yap, J T, Wells, P, Miller, M P, Propper, D, Price, P, Harris, A L
Publicado 2003

Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis

por Hori, K, Saito, S
Publicado 2003

Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes

por Adamina, M, Bolli, M, Albo, F, Cavazza, A, Zajac, P, Padovan, E, Schumacher, R, Reschner, A, Feder, C, Marti, W R, Oertli, D, Heberer, M, Spagnoli, G C
Publicado 2004

Inhibition of transcription factor nuclear factor-κB by a mutant inhibitor-κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell d...

por Duffey, D C, Crowl-Bancroft, C V, Chen, Z, Ondrey, F G, Nejad-Sattari, M, Dong, G, Van Waes, C
Publicado 2000